Treatment

Zalunfiban clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study to assess the safety and efficacy of a single subcutaneous injection of zalunfiban in subjects with ST-elevation myocardial infarction in the pre-hospital setting
This study is testing a new drug, zalunfiban, for people having a severe heart attack (STEMI). It aims to see if a single injection given early helps improve recovery and is safe. The drug is compared to a placebo (dummy drug).
For: Subjects with documented STEMI · presenting with persistent ischemic chest pain (>10 minutes) and new ≥2 mm ST-segment elevation in 2 adjacent ECG leads · in whom the total duration of symptoms to diagnostic ECG is anticipated to be within 4 hours.
Netherlands · Romania · Czechia